trial · primary record
scAAV9/AGA
Aspartylglucosaminuria
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 9 |
| Primary completion | 2032-07-01 |
| Primary endpoint | Incidence, severity, and causality of a single dose of scAAV9/AGA in participants with aspartylglucosaminuria (AGU) |
| Registry ID | NCT07530796 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:45.336Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07530796
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.